drugset / Trial / NCT05859763

99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis

NCT05859763 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

This prospective study will investigate the potential usefulness of 99mTc labeled FAPI SPECT/CT in the diagnosis, treatment response assessment, and follow-up of pulmonary fibrosis.

Timeline

Start
2021-12-12
Primary completion
2023-07-01
Completion
2024-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject 99mTc-HFAPI Diagnostic / imaging agent — Subcutaneous

Indications